Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972238priorityCriticalpatent/ECSP972238A/en
Publication of ECSP972238ApublicationCriticalpatent/ECSP972238A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Hydrogenated Pyridines
(AREA)
Abstract
El invento se refiere a compuestos de fórmula I (gráfico), en la que: R1 y R3 son independientemente hidrógeno, CH3, -CO-(alquilo C1-C6), o -COAr, en el que Ar es fenilo opcionalmente sustituído; R2 es seleccionada entre el grupo formado por pirrolidinilo, hexametilenimino y pieridinilo; o una de sus sales o solvatos farmacéuticamente aceptables, en una forma amorfa.The invention relates to compounds of formula I (graph), wherein: R1 and R3 are independently hydrogen, CH3, -CO- (C1-C6 alkyl), or -COAr, where Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidinyl, hexamethyleneimino and pieridinyl; or one of its pharmaceutically acceptable salts or solvates, in an amorphous form.
ECSP9722381997-08-261997-08-26
AMORPHOUS BENZOTIOFENS, PROCEDURES FOR ITS PREPARATION AND PROCEDURE FOR ITS USE
ECSP972238A
(en)
NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
PROTEASE INHIBITORS, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THE SAME IN THE MANUFACTURE OF A MEDICINAL PRODUCT